Texas Oncology, P.A.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• BioNTech SE1 trial
• US Oncology Research1 trial

Running trials

• Active, not recruiting

  PhII ICb With/Without Erbitux in MBC Pts

  NCT00248287· Phase 2· US Oncology Research· Source

Closed trials

• Recruiting

  Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

  NCT06841055· Phase 2· BioNTech SE· Source